The risk of tumor with the use of recombinant human bone morphogenetic proteins
Introduction Bone morphogenetic proteins (BMPs) are members of a large family of growth factors known as the transforming growth factor-β (TGF-β) superfamily. BMPs are known for their ability to induce bone formation and successfully used in orthopaedic and neurosurgical applications. Various prot...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Russian Ilizarov Scientific Center for Restorative Traumatology and Orthopaedics
2022-08-01
|
| Series: | Гений oртопедии |
| Subjects: |
| _version_ | 1811340760379817984 |
|---|---|
| author | Ural F. Mukhametov Sergey V. Lyulin Dmitry Yu. Borzunov Rinat A. Sufianov Ilgiz F. Gareev |
| author_facet | Ural F. Mukhametov Sergey V. Lyulin Dmitry Yu. Borzunov Rinat A. Sufianov Ilgiz F. Gareev |
| author_sort | Ural F. Mukhametov |
| collection | DOAJ |
| description | Introduction Bone morphogenetic proteins (BMPs) are members of a large family of growth factors known as the transforming growth factor-β (TGF-β)
superfamily. BMPs are known for their ability to induce bone formation and successfully used in orthopaedic and neurosurgical applications. Various
proteins, such as BMP-2, 4, 7, have been reported to have osteoinductive abilities. Recombinant human bone morphogenetic protein-2 (rhBMP-2) and
recombinant human bone morphogenetic protein-7 (rhBMP-7) are widely used for surgical correction of bone defects and spinal fusions. In addition
to the effect on bone formation, BMPs also play a role in cell lineage determination, differentiation, proliferation and apoptosis, and BMP receptors
are present in many cell types including tumor cells. A large number of studies in vitro and in vivo have examined the role of BMPs as stimulating
oncogenesis and metastasis. Therefore, there are some concerns about the use of rhBMPs in clinical practice. Objective In the present study, we aimed
to investigate the causal relationship between the use of rhBMPs and oncogenesis by presenting the results of some preclinical and clinical studies.
Material and methods For a comprehensive search, we used the following databases: PubMed, Embase, the Cochrane Database and Google Scholar
to identifying studies that described a causal relationship between therapeutic use of rhBMPs and oncogenesis. Results The paper represents the
findings on the role and identification of molecular mechanisms of BMP involvement in oncogenesis. In addition to that, the studies reporting a risk of
oncological diseases with the use of rhBMPs in both preclinical and clinical studies were also analyzed. Conclusion There is a need for further clinical
trials in a wide population over a longer timeframe. |
| first_indexed | 2024-04-13T18:46:42Z |
| format | Article |
| id | doaj.art-e3aee1b9a2604ad9b180d17f86a5209e |
| institution | Directory Open Access Journal |
| issn | 1028-4427 2542-131X |
| language | English |
| last_indexed | 2024-04-13T18:46:42Z |
| publishDate | 2022-08-01 |
| publisher | Russian Ilizarov Scientific Center for Restorative Traumatology and Orthopaedics |
| record_format | Article |
| series | Гений oртопедии |
| spelling | doaj.art-e3aee1b9a2604ad9b180d17f86a5209e2022-12-22T02:34:34ZengRussian Ilizarov Scientific Center for Restorative Traumatology and OrthopaedicsГений oртопедии1028-44272542-131X2022-08-0128459259810.18019/1028-4427-2022-28-4-592-598The risk of tumor with the use of recombinant human bone morphogenetic proteinsUral F. Mukhametov0https://orcid.org/0000-0003-3694-3302Sergey V. Lyulin1https://orcid.org/0000-0002-2549-1059Dmitry Yu. Borzunov2https://orcid.org/0000-0003-3720-5467Rinat A. Sufianov3https://orcid.org/0000-0003-4031-0540Ilgiz F. Gareev4https://orcid.org/0000-0002-4965-0835Republican Clinical Hospital. G.G. Kuvatova, Russia, Ufa, Russian FederationMedical Center Carmel", Chelyabinsk, Russian FederationUral State Medical University, Ekaterinburg, Russian FederationSechenov First Moscow State Medical University Moscow, Russian FederationBashkir State Medical University, Ufa, Russian FederationIntroduction Bone morphogenetic proteins (BMPs) are members of a large family of growth factors known as the transforming growth factor-β (TGF-β) superfamily. BMPs are known for their ability to induce bone formation and successfully used in orthopaedic and neurosurgical applications. Various proteins, such as BMP-2, 4, 7, have been reported to have osteoinductive abilities. Recombinant human bone morphogenetic protein-2 (rhBMP-2) and recombinant human bone morphogenetic protein-7 (rhBMP-7) are widely used for surgical correction of bone defects and spinal fusions. In addition to the effect on bone formation, BMPs also play a role in cell lineage determination, differentiation, proliferation and apoptosis, and BMP receptors are present in many cell types including tumor cells. A large number of studies in vitro and in vivo have examined the role of BMPs as stimulating oncogenesis and metastasis. Therefore, there are some concerns about the use of rhBMPs in clinical practice. Objective In the present study, we aimed to investigate the causal relationship between the use of rhBMPs and oncogenesis by presenting the results of some preclinical and clinical studies. Material and methods For a comprehensive search, we used the following databases: PubMed, Embase, the Cochrane Database and Google Scholar to identifying studies that described a causal relationship between therapeutic use of rhBMPs and oncogenesis. Results The paper represents the findings on the role and identification of molecular mechanisms of BMP involvement in oncogenesis. In addition to that, the studies reporting a risk of oncological diseases with the use of rhBMPs in both preclinical and clinical studies were also analyzed. Conclusion There is a need for further clinical trials in a wide population over a longer timeframe.bone morphogenetic proteinsrecombinant human bone morphogenetic proteinsoncogenesiscomplicationtherapy |
| spellingShingle | Ural F. Mukhametov Sergey V. Lyulin Dmitry Yu. Borzunov Rinat A. Sufianov Ilgiz F. Gareev The risk of tumor with the use of recombinant human bone morphogenetic proteins Гений oртопедии bone morphogenetic proteins recombinant human bone morphogenetic proteins oncogenesis complication therapy |
| title | The risk of tumor with the use of recombinant human bone morphogenetic proteins |
| title_full | The risk of tumor with the use of recombinant human bone morphogenetic proteins |
| title_fullStr | The risk of tumor with the use of recombinant human bone morphogenetic proteins |
| title_full_unstemmed | The risk of tumor with the use of recombinant human bone morphogenetic proteins |
| title_short | The risk of tumor with the use of recombinant human bone morphogenetic proteins |
| title_sort | risk of tumor with the use of recombinant human bone morphogenetic proteins |
| topic | bone morphogenetic proteins recombinant human bone morphogenetic proteins oncogenesis complication therapy |
| work_keys_str_mv | AT uralfmukhametov theriskoftumorwiththeuseofrecombinanthumanbonemorphogeneticproteins AT sergeyvlyulin theriskoftumorwiththeuseofrecombinanthumanbonemorphogeneticproteins AT dmitryyuborzunov theriskoftumorwiththeuseofrecombinanthumanbonemorphogeneticproteins AT rinatasufianov theriskoftumorwiththeuseofrecombinanthumanbonemorphogeneticproteins AT ilgizfgareev theriskoftumorwiththeuseofrecombinanthumanbonemorphogeneticproteins AT uralfmukhametov riskoftumorwiththeuseofrecombinanthumanbonemorphogeneticproteins AT sergeyvlyulin riskoftumorwiththeuseofrecombinanthumanbonemorphogeneticproteins AT dmitryyuborzunov riskoftumorwiththeuseofrecombinanthumanbonemorphogeneticproteins AT rinatasufianov riskoftumorwiththeuseofrecombinanthumanbonemorphogeneticproteins AT ilgizfgareev riskoftumorwiththeuseofrecombinanthumanbonemorphogeneticproteins |